OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 8 results.
Search:

SKU Category Vector Description Price Delivery
SC328458 Human cDNA pCMV6-XL5 KCNJ13 (untagged)-Human potassium inwardly-rectifying channel subfamily J member 13 (KCNJ13) transcript variant 3 (10ug) NM_001172417.1 $580 2-3 weeks
RC229820 Human ORF PS100001 KCNJ13 (Myc-DDK-tagged)-Human potassium inwardly-rectifying channel, subfamily J, member 13 (KCNJ13), transcript variant 3 $460 2-3 weeks
RC229820L1 Human ORF PS100064 Lenti-ORF clone of KCNJ13 (Myc-DDK-tagged)-Human potassium inwardly-rectifying channel, subfamily J, member 13 (KCNJ13), transcript variant 3, (10ug) $830 4-5 weeks
RC229820L2 Human ORF PS100071 Lenti-ORF clone of KCNJ13 (mGFP-tagged)-Human potassium inwardly-rectifying channel, subfamily J, member 13 (KCNJ13), transcript variant 3, (10ug) $910 4-5 weeks
RG229820 Human ORF PS100010 KCNJ13 (GFP-tagged) - Human potassium inwardly-rectifying channel, subfamily J, member 13 (KCNJ13), transcript variant 3 $510 2-3 weeks
TF312011 Human shRNA pRFP-C-RS KCNJ13 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 2 Weeks
TG312011 Human shRNA pGFP-V-RS KCNJ13 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TR312011 Human shRNA pRS KCNJ13 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 2 Weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title